title: An Approach to Improve Intestinal Absorption of Poorly Absorbed Water-Insoluble Components via Niemann-Pick C1-Like 1.
abstract: Dietary and biliary cholesterol absorption contributes to the maintenance of tight control of cholesterol homeostasis. Cholesterol is present as mixed micelles formed by bile salts and phospholipids in the intestinal lumen. Recently, Niemann-Pick C1-Like 1 (NPC1L1) transporter was identified as being critical for cholesterol absorption. However, the uptake mechanism of an enveloped substrate of NPC1L1 in whole lipid emulsion particles remains unclear. In this study, we investigated the uptake mechanism of a substrate of NPC1L1 in lipid emulsion particles. We also investigated whether these particles containing cholesterol can improve the intestinal absorption of other lipophilic components via NPC1L1. The uptake of lysophosphatidylcholine (LPC)-4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-propionic acid saccinimidyl ester (BODIPY), a fluorescently labeled phospholipid, in lipid emulsion particles containing cholesterol (1 µM) was significantly increased compared to that without cholesterol in Caco-2 cells. On the other hand, its increased uptake was significantly inhibited by ezetimibe, a selective inhibitor of NPC1L1. These results suggested that not only cholesterol but also some components in lipid emulsion particles are taken up into enterocytes via NPC1L1. We also examined an approach to improve intestinal absorption of a poorly absorbed water-insoluble component, coenzyme Q10 (CoQ10), by this mechanism. The uptake of CoQ10 in lipid emulsion particles containing cholesterol was significantly increased compared to that without cholesterol. Its increased uptake was significantly inhibited by ezetimibe. Though it is still not clear whether CoQ10 is a substrate of NPC1L1, there is a potential for improvement of the absorption of poorly absorbed components by lipid emulsion particles containing cholesterol.
authors.affiliation: Faculty of Pharmaceutical Sciences, Hokkaido University.
authors.forename: Yuto
authors.initials: Y
authors.lastname: Takekawa
authors.forename: Yuki
authors.initials: Y
authors.lastname: Sato
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Yamaki
authors.forename: Mei
authors.initials: M
authors.lastname: Imai
authors.forename: Kazuma
authors.initials: K
authors.lastname: Noto
authors.forename: Masato
authors.initials: M
authors.lastname: Sumi
authors.forename: Yoh
authors.initials: Y
authors.lastname: Takekuma
authors.forename: Ken
authors.initials: K
authors.lastname: Iseki
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Sugawara
mesh_terms: D001896:Boron Compounds / Q000494:pharmacology; D018938:Caco-2 Cells; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004655:Emulsions; D000069438:Ezetimibe / Q000494:pharmacology; D006801:Humans; D007408:Intestinal Absorption; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D026901:Membrane Transport Proteins; D012995:Solubility; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000494:pharmacology; D014867:Water / Q000737:chemistry
chemical_list: C095489:4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; D001896:Boron Compounds; D004655:Emulsions; D008244:Lysophosphatidylcholines; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; C410800:NPC1L1 protein, human; D014867:Water; D014451:Ubiquinone; D002784:Cholesterol; C024989:coenzyme Q10; D000069438:Ezetimibe